This analysis demonstrates new machine learning prognostic scores for multiple myeloma, indicating improved risk stratification accuracy beyond traditional methods.
Key Points
New machine learning models predict survival outcomes, improving personalized risk management in multiple myeloma.
The comprehensive model achieved a C-index of 0.667 for overall survival, indicating effective predictive power.
Utilizing the EMN–HARMONY cohort data of over 14,000 patients allowed for robust model validation and evaluation.
These ML-based scores surpass traditional staging systems, showing effectiveness across different patient populations.